or Try an Advanced Search...

    Morphinans Stocks List

    Symbol Grade Name % Change
    ALKS B Alkermes plc 3.90
    INDV C Indivior PLC 1.12
    PMD D Psychemedics Corporation -0.21
    TRVI D Trevi Therapeutics, Inc. 6.59
    COLL F Collegium Pharmaceutical, Inc. -1.48
    NKTR F Nektar Therapeutics 3.96
    DRRX F DURECT Corporation 17.09
    TTNP F Titan Pharmaceuticals, Inc. -5.60
    VRPX F Virpax Pharmaceuticals, Inc. -3.85
    View As Page of Charts
    Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Opioids Chemical Compounds Euphoriants Organic Compounds Pain Pharmaceutical Schizophrenia Biopharmaceutical Chronic Pain Drug Delivery Drugs Ethers Hydrocodone Hyperactivity Disorder Oxycodone Phenols Analgesics Attention Deficit Hyperactivity Disorder Atypical Antipsychotics Bupivacaine

    Related ETFs - A few ETFs which own one or more of the above listed Morphinans stocks.

    Symbol Grade Name Weight
    PSIL C AdvisorShares Psychedelics ETF 5.34
    MEDX F Horizon Kinetics Medical ETF 3.91
    PSCH B PowerShares S&P SmallCap Health Care Portfolio 3.66
    FBT C First Trust Amex Biotech Index Fund 3.31
    SBIO C ALPS Medical Breakthroughs ETF 3.15
    View all Morphinans ETFs...
    Compare ETFs
    Compare FBT to SBIO Compare MEDX to FBT Compare PSIL to MEDX

        Morphinans Stocks Recent News

        Date Stock Title
        Nov 22 VRPX Virpax Announces Positive Results for the Swine Model Dose Range Finding Study for Probudur™
        Nov 21 VRPX Virpax Announces Agreement with the U.S. Department of Health and Human Services for the Developmental Extension for NES100 Towards IND for Acute and Chronic Non-Cancer Pain Alternative
        Nov 21 ALKS Are Options Traders Betting on a Big Move in Alkermes (ALKS) Stock?
        Nov 21 TRVI Trevi Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference
        Nov 19 INDV Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024
        Nov 18 NKTR Nektar Therapeutics Presents First Preclinical Data from Novel CSF-1 Program, NKTR-422, at 2024 American College of Rheumatology (ACR) Convergence
        Nov 18 VRPX Spartan Capital Securities, LLC Serves as Sole Placement Agent in Virpax Pharmaceuticals, Inc.'s $5.0 Million Public Offering
        Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Opioids Chemical Compounds Euphoriants Organic Compounds Pain Pharmaceutical Schizophrenia Biopharmaceutical Chronic Pain Drug Delivery Drugs Ethers Hydrocodone Hyperactivity Disorder Oxycodone Phenols Analgesics Attention Deficit Hyperactivity Disorder Atypical Antipsychotics Bupivacaine
        Morphinans

        Morphinan is the prototype chemical structure of a large chemical class of psychoactive drugs, consisting of opiate analgesics, cough suppressants, and dissociative hallucinogens, among others.

        More about Morphinans
        Browse All Tags